본문 바로가기
KERD
논문KCI 등재

NO와 Pro-Inflammatory Cytokine의 억제를 통한 胡蘿蔔의 항염증효과

Roots of Daucus carota sativa abrogates acute phase of Inflammation by the Inhibition of NO and Pro-Inflammatory Cytokine Production

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives : Daucus carota sativa has been frequently used as food supplements in many of the Asian countries, and a nutritional medical drug in traditional medicine. This research investigated the effects of Daucus carota sativa extract (DCE) on acute phases of inflammation in Raw 264.7 cells treated with lipopolysaccharide (LPS) in terms of the inhibition of nitric oxide (NO), prostaglandin E2 (PGE2) and pro-inflammatory cytokines production. Methods : NO, PGE2, tumor necrosis factor (TNF)-α, interleukin-1β and interleukin-6 contents were assayed by ELISA, and expressions of inflammation-related proteins such as inducible NO synthase (iNOS) were determined by immunoblot analyses. Results : DCE treatment attenuated the LPS ability to increase the productions of NO and PGE2 as well as the protein level of iNOS in a concentration-dependent manner. Consistently, treatment of the cells with DCE suppressed the production of TNF-α, interleukin-1β and interleukin-6. DCE also caused decreases of inhibitor of κBα phosphorylation induced by LPS in the cells, which means DCE inhibition of NF-κB activity. Furthermore,DCE blocked LPS-induced phosphorylation of p38 and SAPK/JNK. Conclusion : This study showing here may be of help to understand the action mechanism of DCE, and provide the information for the medical use of Daucus carota sativa for the inflammatory disease.

Abstract

Objectives : Daucus carota sativa has been frequently used as food supplements in many of the Asian countries, and a nutritional medical drug in traditional medicine. This research investigated the effects of Daucus carota sativa extract (DCE) on acute phases of inflammation in Raw 264.7 cells treated with lipopolysaccharide (LPS) in terms of the inhibition of nitric oxide (NO), prostaglandin E2 (PGE2) and pro-inflammatory cytokines production. Methods : NO, PGE2, tumor necrosis factor (TNF)-α, interleukin-1β and interleukin-6 contents were assayed by ELISA, and expressions of inflammation-related proteins such as inducible NO synthase (iNOS) were determined by immunoblot analyses. Results : DCE treatment attenuated the LPS ability to increase the productions of NO and PGE2 as well as the protein level of iNOS in a concentration-dependent manner. Consistently, treatment of the cells with DCE suppressed the production of TNF-α, interleukin-1β and interleukin-6. DCE also caused decreases of inhibitor of κBα phosphorylation induced by LPS in the cells, which means DCE inhibition of NF-κB activity. Furthermore,DCE blocked LPS-induced phosphorylation of p38 and SAPK/JNK. Conclusion : This study showing here may be of help to understand the action mechanism of DCE, and provide the information for the medical use of Daucus carota sativa for the inflammatory disease.

참고문헌 (40)

  1. Kim CM, "The Chinese Herbal Dictionary", pp.6124~6126 (1997), Jeongdam
  2. Kim TJ., "Wild Flowers and Resources Plants in Korea (3)", pp.451~ (2008), SNU Press
  3. 노숙령, "인체 폐암세포주 NCI-H1299에 대한 당근 추출물의 항암효과", 동아시아식생활학회지, 12(4), pp.289~298 (2002), 동아시아식생활학회
  4. Han EJ, "Cytotoxicity of Daucus Carota L. on Various Cancer Cells", J Korean Soc Food Sci Nutr, 29, pp.153~160 (2000)
  5. 전은재, "Comet assay를 이용한 케일, 명일엽, 당근, 돌미나리, 녹즙의 Chinese Hamster Lung(CHL) 세포 DNA 손상 보호 효과", Journal of Nutrition and Health, 36(1), pp.24~31 (2003), 한국영양학회
  6. Kim M, "Growth-inhibiting effects of vegetable extracts on Beneficial and Harmful Human Intestinal Bacteria", Agric Chem Biotechnol, 44, pp.65~70 (2001)
  7. Gilani AH, "Cardiovascular Actions of Daucus carota", Arch Pharm Res, 17, pp.150~153 (1994)
  8. 하정림, "국내산 당근 품종별 carotenoid 함량 분석", 한국환경과학회지, 18(10), pp.1135~1141 (2009), 한국환경과학회
  9. Lee YS, "IL-6 mRNA Expression in Mouse Peritoneal Macrophages and NIH3T3 Fibroblasts in Response to Candida albicans", J Microbiol Biotechnol, 10, pp.8~15 (2000)
  10. Higuchi M, "Cytolytic mechanism of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanism acts as synergistically as the major cytolytic mechanism of activated macrophages", J Immunol, 144, pp.1425~1431 (1990)
  11. McDaniel ML, "Cytokines and nitric oxides in islet inflammation and diabetes", Proc Soc Exp Biol Med, 211, pp.24~32 (1996)
  12. Corbett JA, "Intraislet release of interleukin-1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide syntheses", J Exp Med, 181, pp.559~568 (1995)
  13. Cetkovic-Cvrlje M, "TNF and IFN γ potentiate the deleterious effects of IL-1βon mouse pancreatic islets mainly via generation of nitric oxide", Cytokine, 6, pp.399~406 (1994)
  14. Kook YB, "Effect of Hwangryunhaedok-tang on Blood Pressure and Renal Functions in Spontaneously Hypertensive Rats", J of Herbal Prescription, 10, pp.113~129 (2002)
  15. Aeberli D, "Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders", Swiss Med Wkly, 132, pp.414~422 (2002)
  16. Delgado AV, "Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance", P Neuropeptides, 37, pp.355~361 (2003)
  17. The Korean Society of Pathologists, "Pathology", pp.76~108 (2007), KMS
  18. Chen F, "New insights into the role of nuclear factor-kappaB in cell growth regulation", Am J Pathol, 159, pp.387~397 (2001)
  19. Jirik FR, "Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells", J Immunol, 142, pp.144~147 (1989)
  20. Nathan C, "Nitric oxide as a secretory product of mammalian cells", FASEB J, 6, pp.3051~3064 (1992)
  21. Grösch S, "Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors", J Natl Cancer Inst, 98, pp.736~747 (2006)
  22. Sohn GH, "Antitumor Activity of Bupleuri Radix and Artemisiae capillaris Herba and Synergistic Effect with Anticancer Drugs", KOMS, 16, pp.414~432 (1995)
  23. Dong C, "MAP kinases in the immune response", Annu Rev Immunol, 20, pp.55~72 (2002)
  24. Mori M., "Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling", J Nutr, 137, pp.1616S~1620S (2007)
  25. Posadas I, "Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation", Naunyn Schmiedebergs Arch Pharmacol, 361, pp.98~106 (2000)
  26. Yun HY, "Neurobiology of nitric oxide", Crit Rev Neurobiol, 10, pp.291~316 (1996)
  27. Weisz A, "Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterical lipopolysaccharide and NG- monomethyl- L-arginene", Biochem J, 316, pp.209~215 (1996)
  28. McCartney-Francis N, "Suppression of arthritis by an inhibitor of nitic oxide synthase", J Exp Med, 178, pp.749~754 (1993)
  29. Seo WG, "Inhibitory effects of ethyl acetate fraction from Cudrania tricuspidata on the expression of nitric oxide synthase gene in RAW 264.7 macrophages stimulated with interferon and lipopolysaccharide", GenPharmacol, 35, pp.21~28 (2000)
  30. Chiou WF, "Camptothecin suppresses nitric oxide biosynthesis in RAW 264.7 macrophages", Life Sci, 69, pp.625~635 (2001)
  31. Lee BG, "Suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by two-carboline alkaloids extracted from Melia azedarach", Eur J Pharmacol, 406, pp.301~309 (2000)
  32. Seo WG, "The aqueous extract of Rhodiola sachalinensis root enhances the expression of inducible nitric oxide synthase gene in RAW 264.7 macrophages", J Ethnopharmacol, 76, pp.119~123 (2001)
  33. Kawamata H, "Enhanced expression of inducible nitric oxide synthase by Juzen-taiho-to in LPS-activated RAW 264.7 cells, a murine macrophage cell line", Am J Chin Med, 28, pp.217~226 (2000)
  34. Guha M, "LPS induction of gene expression in human monocytes", Cell Signal, 13, pp.85~94 (2001)
  35. Wogensen L, "Pancreatic beta-cell function and interleukin-1β in plasma during the acute phase response in patients with major burn injuries", Eur J Clin Invest, 23, pp.311~319 (1993)
  36. Takabayashi T, "Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells", Surgery, 135, pp.544~554 (2004)
  37. Noh MS, "Inhibitory activities of natural products on lipopolysaccharide induced prostaglandin production in mouse macrophages", Yakhak Hoeji, 42, pp.558~566 (1998)
  38. Surh YJ, "Role of Cyclooxygenase-2 in Carcimogenesis and Its Selective Inhibition for Cancer Chemoprevention", Molecules and cells, 13, pp.8~17 (2001)
  39. Lee AK, "Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α and COX-2 expression by sauchinone effects on I-κBα phosphorylation, C", EBP and AP-1 activation, 2003, pp.139, 11~20
  40. Palombella VJ, "The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κ B", Cell, 78, pp.773~785 (1996)

관련 논문AI추천

이 간행물의 다른 논문 (10건)